Finance News – Ameluz
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Ceo
Tariffs
Investors
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Bse
Xrp
Etf
Stablecoin
Eth
Investment
Blockchain
Ipo
Index
Solana
Sec
Earnings
Trade
Inflation
Revenue
Interest Rates
Sensex
Token
Coinbase
Wall Street
Treasury
Nasdaq
Nse
Federal Reserve
China
Bse Sensex
Traders
Nifty
Sp 500
Gold
Profit
Investor
Tesla
Company
Economy
Wallet Addresses
Web3 Gaming
Land
Pe Multiples
Nifty It
Http
Rockfire Investment Finance
Repayment Plans
Trading Window
Dhb
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Business Insider Markets • Jun 03, 2025
Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid...
The newly granted patent for Biofrontera’s updated topical treatment extends intellectual property rights until 2043, potentially securing long-term revenue streams and competitive...
Read Full Article →